EUCTR2007-005365-35-SE进行中（未招募）不适用
Multicentric, parallel, controlled, randomized, single blind clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertension treated with continous ambulatory or automated peritoneal dialysis. - PDOne
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Chronic renal failure
- •- Stable patients on CAPD with a minimum of 3 bag exchanges including at least one 4-6 hour dwell or patients on APD with at least one daytime exchange lasting for at least 4-6 hours
- •- Hypertensive patients with high blood pressure at inclusion (Office SBP =140 mmHg and/or DBP =90 mmHg) or hypertensive patients receiving antihypertensive medication, including diuretics, disregarding blood pressure values.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •- Low blood pressure (Office sitting SBP =120 mmHg and confirmed by ABPM =105 mmHg mean SBP)
- •- Ortostatic hypotension defined as systolic OBP with a drop of >20 mmHg and symptomatic after 1 minute in standing position
- •- Natremia <130 mmol/l, after two consecutive measurements
- •- Peritonits within one month prior to study start
- •- Exite site and/or tunnel infection
- •- (Patients unable to tolerate 2 L bag exchanges - Cancelled according to
- •amendment 1, dated 04.06.2012 on version 6.0, dated 17.02.2011)
- •- Patients with chronic arrhythmia
研究者
相似试验
进行中（未招募）
1 期
Clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertensioEUCTR2007-005365-35-DKFresenius Medical Care Deutschland GmbH140
进行中（未招募）
1 期
Clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertensioSubjects with renal failure treated with peritoneal dialysisMedDRA version: 17.0Level: LLTClassification code 10009119Term: Chronic renal failureSystem Organ Class: 100000004857EUCTR2007-005365-35-DEFresenius Medical Care Deutschland GmbH140
进行中（未招募）
1 期
Multicenter, parallel, controlled, randomized, single blind clinical evaluation of a new low sodium peritoneal dialysis solution on patients with hypertension treated with continous ambulatory or automated peritoneal dialysis. - PDOneSubjects with renal failure treated with peritoneal dialysisMedDRA version: 9.1Level: LLTClassification code 10009119Term: Chronic renal failureEUCTR2007-005365-35-FRGambro Lundia AB158
进行中（未招募）
不适用
Investigate if a peritoneal dialysis solution with less sodium can improve blood pressure and overhydration when treated on peritoneal dialysis.Patients with chronic renal disease treated on peritoneal dialysis and diagnosed for hypertension.MedDRA version: 14.1Level: PTClassification code 10034660Term: Peritoneal dialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10067974Term: Automated peritoneal dialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10064116Term: Continuous ambulatory peritoneal dialysisSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2007-005365-35-GBFresenius Medcial Care Deutschland GmbH140
进行中（未招募）
不适用
A controlled, randomized, parallel, multi-centre, feasibility study of the oral direct thrombin inhibitor AZD0837, given as extended-release formulation, in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are appropriate for but unable or unwilling to take Vitamin-K antagonist therapyThis is a phase II study to evaluate the feasibility of conducting a study in patients with AF who are appropriate for, but unable or unwilling to take VKA therapy.The intended indication for the product under development is the prevention of stroke and other thromboembolic complicationds associated with atrial fibrillation (AF)MedDRA version: 9.1Level: LLTClassification code 10003658Term: Atrial fibrillationEUCTR2007-001723-36-DKAstraZeneca AB150